http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NI-201800043-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2018-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26ef7c380670c2ae319b9f416371440a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75523ac66f6a080edfe1e5580ce2e44c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37aa0aa4bb32d8737f8dae2046aff62a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a6d7fdebd8b64812fda4ab6677894d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_962d5df0d1cf23690ee86a4f5445964f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7aff63ef91cdc3195ac3fe3f6436e754
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_888b2a4affc7c018bbd8b963d0e2ac98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66a7cb3f50529cdecbabae3e30a47a8a
publicationDate 2018-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NI-201800043-A
titleOfInvention NEW DERIVATIVES OF IMIDAZO [4,5-B] PYRIDINE AS DUAL INHIBITORS OF DYRK1 / CLK1
abstract (Formula I) Compounds of formula (I): useful for the treatment of cancer, neurodegenerative disorders and metabolic disorders.
priorityDate 2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25255
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395233
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13548
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID532989
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408734456
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID458545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67504
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID446302
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID487755
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID32771

Total number of triples: 40.